- Endologix, Inc. ELGX shares dropped 24 percent to $7.47 as the company issued an update on Nellix PMA process. Endologix disclosed that the FDA has requested the company to provide a two-year patient follow-up data from the EVAS-FORWARD IDE study of Nellix System.
- Akers Biosciences Inc AKER shares fell 19 percent to $2.35. Akers Biosciences shares have surged 55.44 percent over the past 52 weeks, while the S&P 500 index has gained 6.20 percent in the same period.
- PDL BioPharma Inc PDLI dropped 18.6 percent to $3.03 after the company reported a proposed $150 million public offering of new convertible senior notes due 2021.
- Eltek Ltd. ELTK shares declined 12.4 percent to $0.937. Eltek posted a Q3 net loss of $0.04 per share, versus a year-ago net profit of $0.06 per share.
- InVitae Corp NVTA shares fell 10.4 percent to $7.64 after the company reported an offering of $40 million common stock.
- Lantheus Holdings Inc LNTH shares dropped 9.5 percent to $9.27. Lantheus announced an offering 3 million shares of common stock.
- Flexion Therapeutics Inc FLXN shares fell 9.4 percent to $18.38. Flexion Therapeutics reported a proposed public offering of common stock.
- Haynes International, Inc. HAYN shares declined 9.2 percent to $39.16. Haynes is expected to announce Q4 results on November 17, 2016. JP Morgan downgraded Haynes International from Overweight to Neutral.
- Top Image Systems Ltd. TISA dropped 9.1 percent to $1.55. On November 15, Top Image Systems reported Q3 earnings of $0.02 per share on revenue of $7.7 million.
- ViaSat, Inc. VSAT declined 8.8 percent to $73.65. ViaSat reported an offering of 6.5 million shares of common stock.
- Lowe's Companies, Inc. LOW shares fell 3.4 percent to $66.73 as the company reported downbeat results for its third quarter on Wednesday.
- Zions Bancorp ZION dropped 3.4 percent to $37.46. Bernstein downgraded Zions Bancorp from Outperform to Market Perform, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in